Ensysce Biosciences, Inc. (ENSC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Add to watchlist

0.6368

-0.0432

(-6.35%)

At close: 04:00PM EDT

0.6260

-0.01

(-1.70%)

After hours:

05:42PM EDT

Loading interactive chart...

ACCESSWIRE
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
New Study to Confirm Overdose Protection Across Full Dosage Range of Breakthrough Therapy Opioid PF614-MPAR SAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical ...
Simply Wall St.
Ensysce Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Ensysce Biosciences ( NASDAQ:ENSC ) First Quarter 2024 Results Key Financial Results Revenue: US$305.7k (down 61% from...
ACCESSWIRE
Ensysce Biosciences Reports First Quarter 2024 Financial Results
PF614's Phase 3 Clinical Plans Affirm the Path to Regulatory Approval FDA Breakthrough Therapy Designation of PF614-MPAR Expedites Clinical Program SAN DIEGO, CA / ACCESSWIRE / May 13, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the ...